Long-term survival with Gemcitabine alone chemotherapy for
non-metastatic advanced pancreatic cancer ; One case |
Hyung Ook Kim, Hungdai Kim, Jun Ho Shin |
Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea |
비전이성 진행 췌장암에서 Gemcitabine 단독 항암 화학요법을 통한 장기 생존 1예 |
김형욱, 김흥대, 신준호 |
성균관대학교 의과대학 강북삼성병원 외과학교실 |
Corresponding Author:
Jun Ho Shin ,Tel: +82-2-2001-2138, Fax: +82-2-2001-2131, Email: junho0521.shin@samsung.com |
Received: April 10, 2009; Accepted: May 7, 2009. |
|
Share :
|
ABSTRACT |
We report a 69-year-old male patient with non-metastatic advanced pancreatic cancer confirmed by abdominal computed
tomography and intraoperative biopsy. He presented with long-term survival more than 30 months without disease progression
or complication following palliative surgery and chemotherapy, after palliative choledochojejunostomy and postoperative gemcitabine
alone chemotherapy. |
Keywords:
Pancreatic cancer | Obstructive jaundice | Palliation |
|
|
|